Pentobarbital versus thiopental in the treatment of refractory intracranial hypertension in patients with traumatic brain injury: a randomized controlled trial
2008

Comparing Pentobarbital and Thiopental for Brain Injury Treatment

Sample size: 44 publication Evidence: moderate

Author Information

Author(s): Pérez-Bárcena Jon, Llompart-Pou Juan A, Homar Javier, Abadal Josep M, Raurich Joan M, Frontera Guillem, Brell Marta, Ibáñez Javier, Ibáñez Jordi

Primary Institution: Son Dureta University Hospital

Hypothesis

Thiopental is more effective than pentobarbital in controlling intracranial pressure in patients with severe traumatic brain injury.

Conclusion

Thiopental appeared to be more effective than pentobarbital in controlling intracranial hypertension refractory to first-tier measures.

Supporting Evidence

  • Thiopental was more effective than pentobarbital in controlling intracranial pressure.
  • The incidence of adverse effects was similar in both treatment groups.
  • The study included 44 patients over a 5-year period.

Takeaway

This study looked at two medicines used to help patients with serious brain injuries. It found that one medicine worked better than the other to help lower pressure in the brain.

Methodology

A prospective, randomized cohort study comparing the effectiveness of pentobarbital and thiopental in controlling refractory intracranial hypertension.

Potential Biases

Imbalance in cranial tomography characteristics and different dosages between treatment groups.

Limitations

The study was not blinded and had a small sample size.

Participant Demographics

Patients aged 15 to 76 with severe traumatic brain injury and refractory intracranial hypertension.

Statistical Information

P-Value

0.027

Confidence Interval

95% CI 1.2 to 21.9

Statistical Significance

p=0.027

Digital Object Identifier (DOI)

10.1186/cc6999

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication